Using this approach, we investigated the effects of KMO inhibition on seizures, depressive-like behaviors, and cognitive function in epileptic mice, thereby providing novel insights and a robust scientific foundation for developing therapeutic strategies targeting epilepsy-associated depression. The gene discussed is KMO; the disease is major depressive disorder.